The mechanism of cryptolepine-induced cell death

Journal of Pharmacology and Toxicology

Volumn 3, Issue 4, 2008, Pages 291-301

  Ansah, C ^a   Zhu, H ^b   Goderham, N J ^b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Cell death; Cryptolepine; Hepatoma HepG2 cells; Human lymphoblastoid MCL 5 cells; Necrosis

Indexed keywords

CASPASE 3; CRYPTOLEPINE; CYTOCHROME C; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROTEIN BAX;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL STRAIN V 79; CELL STRUCTURE; CHEMICAL ANALYSIS; CHINESE HAMSTER; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME DEGRADATION; FIBROBLAST CULTURE; HEPATOMA CELL; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; STAINING;

EID: 45849085439     PISSN: 1816496X     EISSN: None     Source Type: Journal    
DOI: 10.3923/jpt.2008.291.301     Document Type: Article

References (44)

1. Ankarcrona, M., J.M. Dypbukt, E. Bonfoco, B. Zhivotovsky, S. Orrenius, S.A. Lipton and P. Nicotera, 1995. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron, 15 (4): 961-973.
2. Ansah, C. and N.J. Gooderham, 2002. The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic. Toxicol. Sci., 70 (2): 245-251.
3. Ansah, C. and N.J. Gooderham, 2005. Reactive oxygen species is associated with cryptolepine cytotoxicity. J. Sci. Tech., 25 (1): 1-10.
4. Ashida, H., K. Kihara, Y. Nonaka, I. Fukuda, B. Shiotani and T. Hashimto, 2001. The heterocyclic amine, 3-amino-1, 4-dimethyl-5H-pyrido [4,3-b] indole induces apoptosis in cocultures of rat parenchymal and nonparenchymal cells liver cells. Toxicol. Applied Pharmacol., 177 (1): 59-67.
5. Bonjean, K., M.C. De Pauw-Gillet, M.P. Defresne, P. Colson, C. Houssier, L. Dassonneville, C. Bailly, R. Greimers, C. Wright, J. Quetin-Leclercq, M. Tits and L. Angenot, 1998. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry, 37 (15): 5136-5146.
6. Caelles, C., A. Helmberg and M. Karin, 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370 (6486): 220-223.
7. Cohen, G.M., 1997. Caspases: The executioners of apoptosis. A review: Biochem. J., 326 (Pt I): 1-16.
8. Crespi, C.L., F.J. Gonzalez, D.T. Steimel, T.R. Turner, H.V. Gelboin, B.W. Penman and R.A. Langenbach, 1991, Metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: Application to mutagenicity testing. Chem. Res. Toxicol., 4 (5): 566-572.
9. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, M.A. Hotz, P. Lassota and F. Traganos, 1992. Features of apoptotic cells measured by flow cytometry. Cytometry, 13 (8). 795-808.
10. Dassonneville, L., A. Lansiaux, A. Wattelet, N. Wattez, C. Mahieu S. Van Miert, L. Pieters and C. Bailly, 2000. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: Relation to drug-induced apoptosis. Eur. J. Pharmacol., 409 (1). 9-18.
11. Desagher, S. and J.C. Martinou, 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol., 10 (9): 369-377.
12. Dwuma-Badu, D., J.S.K. Ayim, F.N.I.Y. Fiagbe, J.E. Knapp, P.L. Jr. Schiff and D.J. Slatkin, 1978. Constituents of West African medicinal plants XX: Quindoline from Cryptolepis sanguinol enta. J. Pharm. Sci., 67 (3): 433-434.
13. Gores, G.J., B. Herman and J.J. Lemasters, 1990. Plasma membrane bleb formation and rupture: A common feature of hepatocellular injury. Hepatology, 11(4):690-698.
14. Halestrap, A.P., K.Y. Woodfield and C.P. Connem, 1997. Oxidative stress, thiol reagents and membrane-potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem., 272 (6): 3346-3354.
15. Hampton, M.B. and S. Orrenius, 1997. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS. Lett., 414 (3): 552-556.
16. Kerr, J.F., 1971. Shrinkage necrosis: A distinct mode of cellular death. J. Pathol., 105 (1): 13-20.
17. Kerr, J.F., A.H. Wyllie and A. Currie, 1972. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26 (4): 239-257.
18. Khodarev, N.N., I.A. Sokolova and A.T. Vaughan, 1998. Mechanisms of induction of apoptotic DNA fragmentation. Int. J. Radiat. Biol., 73 (5): 455-467.
19. Kidd, V.J., 1998. Proteolytic activities that mediate apoptosis. Annu. Rev. Physiol., 60 (1): 533-573.
20. Kirby, G.C., A. Paine, D.C. Warhurst, B.K. Noamesi and G.D. Philipson, 1995. In vitro and in vivo anti-malarial activity of cryptolepine, a plant derived indoquinoline. Phytother. Res., 9 (5): 359-363.
21. Kuwana, T., J.J. Smith, M. Muzio, V. Dixit, D.D. Newmeyer and S. Kornbluth, 1998. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem., 273 (26): 16589-16594.
22. Lee, Y.J. and E. Shacter, 1999. Oxidative stress inhibits apoptosis in human lymphoma cells. J. Biol. Chem., 274 (28): 19792-19798.
23. Leist, M., B. Single, A.F. Castoldi, S. Kuhnle and P. Nicotera, 1997. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J. Exp. Med., 185 (98): 1481-1486.
24. Lisgarben, J.N., M. Coll, J. Portugal, C.W. Wright and J. Aymami, 2002. The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites. Nat. Struct. Biol., 9 (1): 57-60.
25. Liu, X., C.N. Kim, J. Yang, R. Jemmerson and X. Wang, 1996. Induction of apoptotic programme in cell-free extracts: Requirements for dATP and cytochrome c. Cell, 86 (1): 147-157.
26. Nakano, K. and K.H. Vousden, 2001. PUMA, a novel pro-apoptotic gene, is induced by p53. Mol. Cell, 7 (3): 683-694.
27. Nunez, G., M.A. Benedict, Y. Hu and N. Inohara, 1998. Caspases: The proteases of the apoptotie pathway. Oncogene, 17 (25): 3237-3245.
28. Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi and N. Tanaka, 2000a. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288 (5468): 1053-1058.
29. Oda, K., H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura and Y. Taya, 2000b. p53 AIP1, a potential mediator of p53-dependent apoptosis and its regulation by Ser-46-phosphorylated p53. Cell, 102 (6): 849-862.
30. Owen-Schaub, L.B., W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, J.A. Roth, A.B. Deisseroth, W. W. Zhang and E. Kruzel, 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol., 15 (6): 3032-3040.
31. Polla, B.S., M.R. Jacquier-Sarlin, S. Kantengwa, E. Mariethoz, T. Hennet, F. Russo-Marie and A. Cossarizza, 1996. TNF alpha alters mitochondrial membrane potential in L929 but not in TNF alpha-resistant L929.12 cells: Relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity. Free Radic. Res., 25 (2): 125-131.
32. Polyak, K., Y. Xia, J.L. Zweier, K.W. Kinzler and B. Vogelstein, 1997. A model for p53-induced apoptosis. Nature, 389 (6648): 300-305.
33. Porter, A.G. and R.U. Janicke, 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ, 6 (2): 99-104.
34. Samali, A., H. Nordgren, B. Zhivotovsky, E. Peterson and S. Orrenius, 1999. A comparative study of apoptosis and necrosis in HepG2 cells: Oxidant-induced caspase inactivation leads to necrosis. Biochem. Biophys. Res. Commun., 255 (1): 6-11.
35. Shimizu, S., Y. Eguchi, W. Kamiike, Y. Itoh, J. Hasegawa, K. Yamabe, Y. Otsuki, H. Matsuda and Y. Tsujimoto, 1996. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res., 56: 2161-2166.
36. Shimizu, T. and Y. Pommier, 1997. Camptothecin-induced apoptosis in p53-null human leukemia HL, 60 cells and their isolated nuclei: Effects of the protease inhibitors, Z-VAD-fmk and dichloroisoccumarin suggest an involvement of both caspases and serine proteases. Leukemia, 11 (8): 1238-1244.
37. Stennicke, H.R., J.M. Jurgensmeier, H. Shin, Q. Deveraux, B.B. Wolf, X. Yang, Q. Zhou, H.M. Ellerby, L.M. Ellerby, D. Bredesen, D.R. Green, J.C. Reed, C.J. Froelich and G.S. Salvesen, 1998. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem., 273 (42): 27084-27090.
38. Tackie, A.N., M.H.N. Sharaf, P.L. Schiff, G.L. Boye, R.C. Crouch and G.E. Martin, 1991. Assignment of the proton and carbon NMR spectra of the indoloquinoline alkaloid cryptolepine. J. Heterocyclic Chem., 28 (5): 1429-1435.
39. Vermes, I., C. Haanen, H. Steffens-Nakken and C. Reutelingsperger, 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184 (1): 39-51.
40. Wolfe, J.T., D. Ross and G.M. Cohin, 1994. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS. Lett., 352 (1): 58-62.
41. Woo, M., R. Hakem, M.S. Soengas, G.S. Duncan, A. Shahinian, D. Kagi, A. Hakem, M. McCurrach, W. Khoo, S.A. Kaufman, G. Senaldi, T. Howard, S.W. Lowe and T.W. Mak, 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev., 12 (6): 806-819.
42. Wright, C.W., J. Addae-Kyereme, A.G. Breen, J.E. Brown, M.F. Cox, S.L. Croft, Y. Gokcek, H. Kendrick, R.M. Phillips and P.L. Pollet, 2001. Synthesis and evaluation of cryptolepine analogues for their potential as antimalarial agents. J. Med. Chem., 44 (19): 3187-3194.
43. Wyllie, A.H., J.F. Kerr and A.R. Currie, 1980. Cell Death: The significance of apoptosis. Int. Rev. Cytol., 68 (1): 251-306.
44. Yu, J., L. Zhang, P.M. Hwang, K.W. Kinzler and B. Vogelstein, 2001. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell, 7 (3): 673-682.